Twenty-eight months progression-free survival after pyrotinib therapy for HER2-positive recurrent ovarian clear cell carcinoma: a case report
Jing Wu(Nanjing Medical University), Qian Li(Soochow University), Xi Guo(Zhongshan Hospital), Yang You(East China University of Science and Technology), Qi Zhang(Sun Yat-sen University), Chenlu Zhang(Northwestern University), Rongyuan Zhuang(Zhongshan Hospital), Yuhong Zhou(Sun Yat-sen University)
Cited by 7
Related Papers
Progress in Hydrogels for Skin Wound Repair
|Macromolecular Bioscience|2022|251
The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction
|Frontiers in Endocrinology|2022|222
Structural basis of GPBAR activation and bile acid recognition
|Nature|2020|190
In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms
|Journal of Ethnopharmacology|2005|141
Building HVAC control with reinforcement learning for reduction of energy cost and demand charge
|Energy and Buildings|2021|134